Last reviewed · How we verify

NCT03117504

Assessment of Prevalence of Stress Urinary Incontinence During Pregnancy

Suspended Last updated 18 April 2017
What this trial tests

trial testing questionnaire in Stress Urinary Incontinence in 500 participants. Suspended.

Timeline
5 January 2016
Primary endpoint
20 May 2017
20 July 2017

Quick facts

Lead sponsorAin Shams Maternity Hospital
StatusSuspended
Study typeOBSERVATIONAL
Enrollment500
Start date5 January 2016
Primary completion20 May 2017
Estimated completion20 July 2017
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams Maternity Hospital

Who can join

Eligibility, female only, with Stress Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stress urinary incontinence is the most common type of incontinence during pregnancy.our study aims at determining the prevalence in the first and third trimesters and the associated risk factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of questionnaire

Trials testing the same drug.

Other recruiting trials for Stress Urinary Incontinence

Currently open trials in the same condition.

Other Ain Shams Maternity Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03117504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing